Stefan Störk

Active 1991–2025

156
Papers
18,368
Citations
68
h-index
131
i10-index

Citations

Citations per year for Stefan Störk1992: 1 citations1993: 4 citations1994: 4 citations1995: 2 citations1996: 2 citations1997: 3 citations1998: 2 citations1999: 2 citations2001: 3 citations2002: 13 citations2003: 17 citations2004: 7 citations2005: 14 citations2006: 15 citations2007: 15 citations2008: 26 citations2009: 38 citations2010: 71 citations2011: 56 citations2012: 93 citations2013: 84 citations2014: 103 citations2015: 82 citations2016: 114 citations2017: 108 citations2018: 144 citations2019: 615 citations2020: 689 citations2021: 716 citations2022: 588 citations2023: 437 citations2024: 794 citations2025: 347 citations2026: 18 citations2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,619 citing papers, 15.3% of this breakdownGermany: 927 citing papers, 8.7% of this breakdownUnited Kingdom: 901 citing papers, 8.5% of this breakdownItaly: 669 citing papers, 6.3% of this breakdownCanada: 495 citing papers, 4.7% of this breakdownNetherlands: 450 citing papers, 4.2% of this breakdownFrance: 418 citing papers, 3.9% of this breakdownSpain: 376 citing papers, 3.6% of this breakdownChina: 342 citing papers, 3.2% of this breakdownSwitzerland: 306 citing papers, 2.9% of this breakdownAustralia: 305 citing papers, 2.9% of this breakdownSweden: 301 citing papers, 2.8% of this breakdown
0%15.3%Other 33%

Fields

  • Medicine85.5%
  • Biochemistry, Genetics and Molecular Biology6.4%
  • Neuroscience1.9%
  • Health Professions1.5%
  • Computer Science0.9%
  • Immunology and Microbiology0.7%
  • Other3.1%

Topics

  • Heart Failure Treatment and Management5.4%
  • Cardiovascular Function and Risk Factors4.5%
  • Cardiac Health and Mental Health3.1%
  • Antiplatelet Therapy and Cardiovascular Diseases2.6%
  • Atrial Fibrillation Management and Outcomes2.3%
  • Cardiac Imaging and Diagnostics2.2%
  • Other79.9%

Coauthors

All papers

Open in search
  1. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Peter Verhamme, Dragoş Vinereanu, Jae‐Hyung Kim, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Philippe Gabríel Steg, Kaj Metsärinne, Nancy Cook Bruns, Frank Misselwitz, Edmond Chen, Darryl P. Leong, Salim Yusuf - New England Journal of Medicine 2017 cited by 2,412

  2. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2018 cited by 740

  3. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nebojša Lalić, Seppo Lehto, Dragan Lović, S. Mancas, Linda Mellbin, Davor Miličić, Erkin М Мirrakhimov, Р. Г. Оганов, Nana Pogosova, Željko Reiner, Stefan Störk, Lâle Tokgözoğlu, Costas Tsioufis, Duško Vulić, David Wood, on behalf of the EUROASPIRE Investigators* - European Journal of Preventive Cardiology 2019 cited by 937

  4. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Zhu, Yan Liang, Patricio López‐Jaramillo, Ajay K. Kakkar, Alexander Parkhomenko, Lars Rydén, Nana Pogosova, Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Dragoş Vinereanu, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Kaj Metsärinne, Keith A.A. Fox, Salim Yusuf - Gastroenterology 2019 cited by 477

  5. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - EClinicalMedicine 2022 cited by 174

  6. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Betty Muthoni Gikonyo, Dan Gikonyo, Roger J. Hajjar, Kunitoshi Iseki, Hideki Ishii, Greg Knoll, Colin R. Lenihan, Krista L. Lentine, Edgar V. Lerma, Etienne Macedo, Patrick B. Mark, Eisei Noiri, Alberto Palazzuoli, Roberto Pecoits‐Filho, Bertram Pitt, Claudio Rigatto, Patrick Rossignol, Soko Setoguchi, Manish M. Sood, Stefan Störk, Rita S. Suri, Karolina Szummer, Sydney Tang, Navdeep Tangri, Aliza Thompson, Krishnaswami Vijayaraghavan, Michael D. Walsh, Angela Yee‐Moon Wang, Matthew R. Weir - Kidney International 2019 cited by 435

  7. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - EClinicalMedicine 2022 cited by 187

  8. Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2020 cited by 212

  9. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johan De Sutter, Jaap W. Deckers, Mirza Dilić, М. М. Долженко, H. Druais, Vilnis Dzērve, Andrejs Ērglis, Zlatko Fras, D. Gaita, Nina Gotcheva, D.E. Grobbee, Viveca Gyberg, Hosam Hasan Ali, Peter U. Heuschmann, Arno W. Hoes, Piotr Jankowski, Nebojša Lalić, Seppo Lehto, Dragan Lović, Aldo P. Maggioni, S. Mancas, Pedro Marques‐Vidal, Linda Mellbin, Davor Miličić, E. Mirrakhimov, Р. Г. Оганов, Nana Pogosova, Željko Reiner, Lars Rydén, Martin Stagmo, Stefan Störk, Jouko Sundvall, Lâle Tokgözoğlu, Konstantinos Tsioufis, Duško Vulić, David Wood, David A. Wood, Kornelia Kotseva, Catriona Jennings, Agnieszka Adamska, S. Adamska, Lars Rydén, Linda Mellbin, J. Tuomilehto, Oliver Schnell, H. Druais, Edoardo Fiorucci, Myriam Glémot, Florian Larras, V. Missiamenou, Aldo P. Maggioni, C. Taylor, Teresa Ferreira, Katell Lemaitre, Dirk De Bacquer, Guy De Backer, Laura Råman, Jouko Sundvall, Daniel-Henri Desmedt, Johan De Sutter, Anne‐Marie Willems, Michel De Pauw, Pieter Vervaet, J. Bollen, E. Dekimpe, N. Mommen, G. Van Genechten, Paul Dendale, C A Bouvier, Patrick Chenu and 475 more - Atherosclerosis 2019 cited by 369

  10. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert G. Hart, Salim Yusuf, JORGELINA SALA, Luis R Cartasegna, MARISA VICO, Miguel Hominal, Eduardo Hasbani, Alberto Caccavo, Cesar Javier Zaidman, DANIEL VOGEL, Adrian D. Hrabar, Pablo Schygiel, Carlos Alberto Cuneo, Hugo A Luquez, Ignacio MacKinnon, Rodolfo Andrés Ahuad Guerrero, Juan Pablo Costabel, INES PALMIRA BARTOLACCI, Oscar Montaña, María Antonietta Barbieri, Oscar Gómez Vilamajó, RUBEN OMAR GARCIA DURAN, Lilia Beatriz Schiavi, Marcelo Garrido, ADRIAN INGARAMO, Anselmo P. Bordonava, MARIA JOSE PELAGAGGE, LEONARDO NOVARETTO, JUAN PABLO ALBISU DI GENNERO, LUZ MARIA IBANEZ SAGGIA, MOIRA ALVAREZ, Néstor A. Vita, Stella M. Macı́n, Ricardo D. Dran, Marcelo Cardona, Luis Guzman, RODOLFO JUAN SARJANOVICH, Jesus Cuadrado, SEBASTIAN NANI, MARCOS RAUL LITVAK BRUNO, Carolina Chacón, Laura Maffei, Diego Grinfeld, NATALIA VENSENTINI, CLAUDIO RODOLFO MAJUL, Héctor Luciardi, PATRICIA DEL CARMEN GONZALEZ COLASO, FREDY ANTONI FERRE PACORA, PAUL VAN DEN HEUVEL, Peter Verhamme, Bavo Ector, PHILIPPE DEBONNAIRE, Philippe van de Borne, JEAN LEROY, Herman Schroë, Pascal Vranckx, Ivan Elegeert, E Hoffer, KARL DUJARDIN, CLARISSE INDIO DO BRASIL, Dalton Bertolim Précoma, JOSE ANTONIO ABRANTES, Euler Roberto Fernandes Manenti, Gilmar Reis, José Francisco Kerr Saraiva, Lília Nigro Maia, Mauro Esteves Hernandes, Paulo Roberto Ferreira ROSSI, Fabio Rossi dos Santos, Sérgio Luiz Zimmermann and 544 more - The Lancet 2017 cited by 880

  11. Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy

    Authors: , , , , , , , , , - Circulation 2009 cited by 484

  12. Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - EClinicalMedicine 2024 cited by 57

  13. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Željko Reiner, Martin Stagmo, Stefan Störk, Lâle Tokgözoğlu, Duško Vulić, on behalf of the EUROASPIRE Investigators - European Journal of Preventive Cardiology 2015 cited by 1,004

  14. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monika Kraus, Dagmar Krefting, Sonja Kunze, Florian Kurth, Wolfgang Lieb, Lena J. Lippert, Roberto Lorbeer, Bettina Lorenz‐Depiereux, Corina Maetzler, Olga Miljukov, Matthias Nauck, Daniel Pape, Valentina O. Püntmann, Lennart Reinke, Christoph Römmele, Stefanie Rudolph, Julian Saß, Christian Schäfer, J. Schaller, Mario Schattschneider, Christian Scheer, Margarete Scherer, Sein Schmidt, Julia Wendel, Kristina Seibel, Dana Stahl, Fridolin Steinbeis, Stefan Störk, Maike Tauchert, Johannes Tebbe, Charlotte Thibeault, Nicole Toepfner, Kathrin Ungethüm, István Vadász, Heike Valentin, Silke Wiedmann, Thomas Zöller, Eike Nagel, Michael Krawczak, Christof von Kalle, Thomas Illig, Stefan Schreiber, Martin Witzenrath, Peter U. Heuschmann, Jörg Janne Vehreschild - European Journal of Epidemiology 2022 cited by 63

  15. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Zhu, Yan Liang, Patricio López‐Jaramillo, Ajay K. Kakkar, Alexander Parkhomenko, Lars Rydén, Nana Pogosova, Antonio Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek Guzik, Dragoş Vinereanu, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Kaj Metsärinne, Keith A.A. Fox, Salim Yusuf - Gastroenterology 2019 cited by 154

  16. Long‐term outcome of enzyme‐replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications

    Authors: , , , , , , , , - Journal of Internal Medicine 2013 cited by 218

  17. Rationale and Design of the DIGIT-HF Trial (DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure): A Randomized, Double-Blind, Placebo-Controlled Study

    Authors: , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2019 cited by 83

  18. Copeptin in the Differential Diagnosis of the Polydipsia-Polyuria Syndrome—Revisiting the Direct and Indirect Water Deprivation Tests

    Authors: , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2011 cited by 185

  19. European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology

    Authors: , , , , , , , , , , , , , , , - European Journal of Heart Failure 2022 cited by 58

  20. Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis

    Authors: , , , , , , , , , , - Circulation 2009 cited by 705

  21. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2016 cited by 275

  22. Effect of Combined Systolic and Diastolic Functional Parameter Assessment for Differentiation of Cardiac Amyloidosis From Other Causes of Concentric Left Ventricular Hypertrophy

    Authors: , , , , , , , , , , - Circulation Cardiovascular Imaging 2013 cited by 199

  23. Relation of Burden of Myocardial Fibrosis to Malignant Ventricular Arrhythmias and Outcomes in Fabry Disease

    Authors: , , , , , , , - The American Journal of Cardiology 2014 cited by 147

  24. A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Renate Hammerstingl, Joanna Haraźny, Michael Heckel, Andrea Heyd-Schramm, Joachim Hoyer, Rolf Janka, Oliver Jung, Markus Ketteler, Christina Klaeffling, Claudius Kleinert, Marianne Kleinert, Arnfried U. Klingbeil, Thorsten Klink, Benjamin Koch, Judith Kosowski, Michael Leidig, Jens Lutz, Mohamed Marwan, Maria Moritz, Brigitte Moye, Holger Naujoks, Kai‐Olaf Netzer, Ulrike Raff, Clemens Reichert, Imke Reimer, Jurij Ribel, Sophie Richter, Christian Ritter, Sarah Rudolf, Beate Schamberger, Michael Schmid, Thomas Schmiedeke, Andreas M. Schmitt, Heike Schneider, Reinhard Schneider, Cord Schneuzer, M Schöffauer, Lothar Schramm, Sabine Schütterle, Susanne Schwedler, Ewelina Sobkowiak, Daniel Sollinger, Frank Strutz, Sebastian Toncar, Vladimir Vasiljuk, Thomas Vogl, Thorsten Walther, Julia Weinmann‐Menke, Bettina Wirth, Hendrick Witsch, Paul Würmell, Raoul Zeltner, Josef Zimmermann - Kidney International 2019 cited by 90